Lead-212 Supply

About Thor Medical

Thor Medical's mission is to establish a profitable, world-leading supply of alpha-emitting radionuclides for cancer treatment. Its key achievement is the development and pilot-scale operation of a novel, closed-loop production process that extracts isotopes from natural thorium-232, offering a sustainable and geopolitically secure alternative to reactor-dependent methods. The company's strategy is to scale its 'AlphaOne' commercial production facility to meet burgeoning global demand, positioning itself as a critical enabler within the radiopharmaceutical ecosystem without developing its own drug candidates.

Therapeutic Areas

Other Various Cancers (via partners) Drugs